PN
PNTG.US Pennant Group Inc
- Market cap
- USD 1.28B
- P/E
- 36.5x
- P/B
- 3.47x
- ROE
- 9.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is PNTG.US undervalued?
Graham numberPNTG.US trades 137.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Pennant Group Inc fundamental analysis
No fundamental analysis for Pennant Group Inc yet.
Pennant Group Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Pennant Group Inc
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial nee…
Full company profilePennant Group Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Pennant Group Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 217M | 251M | 286M | 339M | 391M | 440M | 473M | 545M | 695M | 948M | 1.18B |
| Gross Profit | 28.3M | 32.4M | 42.4M | 44.6M | 54.9M | 48.6M | 58.6M | 67.0M | 93.8M | 122M | 160M |
| Operating Income | 13.0M | 15.4M | 20.6M | 5.67M | 18.9M | 4.70M | 12.7M | 25.2M | 38.1M | 51.4M | 69.0M |
| EBITDA | 15.8M | 17.9M | 23.6M | 9.48M | 23.8M | 9.46M | 17.6M | 30.6M | 44.4M | 60.8M | 72.6M |
| Net Income | 7.89M | 9.87M | 15.7M | 2.55M | 15.7M | 2.70M | 6.64M | 13.4M | 22.6M | 29.6M | 36.3M |
| EPS | 0.28 | 0.35 | 0.56 | 0.09 | 0.52 | 0.09 | 0.22 | 0.44 | 0.70 | 0.84 | 1.00 |
| Balance Sheet | |||||||||||
| Total Assets | - | 88.3M | 98.2M | 448M | 507M | 530M | 512M | 540M | 680M | 968M | 1.04B |
| Total Liabilities | - | 28.4M | 32.9M | 377M | 406M | 416M | 386M | 394M | 368M | 594M | 623M |
| Shareholders' Equity | - | 55.0M | 55.9M | 71.1M | 96.6M | 110M | 121M | 140M | 293M | 333M | 376M |
| Cash & Short-term Investments | - | 36.0K | 41.0K | 402K | 43.0K | 5.19M | 2.08M | 6.06M | 24.2M | 17.0M | 18.4M |
| Total Debt | - | - | - | 335M | 319M | 355M | 327M | 330M | 273M | 453M | 481M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 16.4M | 17.3M | 23.3M | 9.55M | 50.2M | -18.2M | 9.04M | 33.1M | 39.3M | 48.3M | 58.1M |
| Capital Expenditure | 3.47M | 3.13M | 3.60M | 6.71M | 7.25M | 6.30M | 14.2M | 8.11M | 8.99M | 22.0M | 42.5M |
| Free Cash Flow | 12.9M | 14.1M | 19.7M | 2.84M | 43.0M | -24.5M | -5.13M | 25.0M | 30.3M | 26.3M | 15.6M |
| Ratios | |||||||||||
| ROE | - | 17.9% | 28.1% | 3.6% | 16.3% | 2.4% | 5.5% | 9.5% | 7.7% | 8.9% | 9.7% |
| ROA | - | 11.2% | 16.0% | 0.6% | 3.1% | 0.5% | 1.3% | 2.5% | 3.3% | 3.1% | 3.5% |
| Net Profit Margin | 3.6% | 3.9% | 5.5% | 0.8% | 4.0% | 0.6% | 1.4% | 2.5% | 3.2% | 3.1% | 3.1% |
| Debt to Equity | - | - | - | 4.71x | 3.30x | 3.22x | 2.70x | 2.35x | 0.93x | 1.36x | 1.28x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Pennant Group Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | USD 1.14M | 0.04 | 7.2% |
| 2019 | USD 11.6M | 0.39 | 455.6% |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Pennant Group Inc
- Insiders 5.04%
- Institutions 94.96%
- Public & others 0.00%
- Shares outstanding 35.1M
- Free float 33.4M
Top funds holding PNTG.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 1.05M | 2.99% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 862K | 2.46% | 0.00% | Oct 2026 |
| Wasatch Small Cap Growth Investor | 672K | 1.92% | +3.71% | Sep 2026 |
| Columbia Acorn Inst | 562K | 1.60% | -0.38% | Sep 2026 |
| First Eagle Small Cap Opportunity I | 522K | 1.49% | +0.90% | Sep 2026 |
| VT De Lisle America B USD | 503K | 1.43% | +1.09% | Oct 2026 |
| AB Small Cap Growth A | 397K | 1.13% | 0.00% | Sep 2026 |
| Rhenman Healthcare Equity L/S RC2 SEK | 377K | 1.08% | +5.60% | Jan 2026 |
| Fidelity Small Cap Index | 373K | 1.06% | 0.00% | Aug 2026 |
| iShares Russell 2000 Growth ETF | 325K | 0.93% | -0.38% | Oct 2026 |
| Victory RS Partners A | 314K | 0.90% | +13.91% | Sep 2026 |
| Wasatch Micro Cap | 291K | 0.83% | -39.83% | Sep 2026 |
| Fidelity Small Cap Discovery | 269K | 0.77% | 0.00% | Aug 2026 |
| Fidelity Series Small Cap Discovery | 241K | 0.69% | 0.00% | Aug 2026 |
| First Trust Small Cap Gr AlphaDEX® ETF | 220K | 0.63% | +0.43% | Oct 2026 |
| Nuveen Quant Small Cap Equity R6 | 201K | 0.57% | +1.62% | Sep 2026 |
| Vanguard Russell 2000 ETF | 198K | 0.57% | +1.07% | Sep 2026 |
| CREF Total Global Stock Account R3 | 197K | 0.56% | -4.46% | Sep 2026 |
| Schwab US Small-Cap ETF™ | 185K | 0.53% | +0.23% | Oct 2026 |
| Fidelity Extended Market Index | 160K | 0.46% | -5.46% | Sep 2026 |
Top institutions holding PNTG.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 2.96M | 8.44% | +8.95% | Jun 2026 |
| Van Berkom and Associates Inc | 2.17M | 6.17% | -8.59% | Sep 2026 |
| Wasatch Advisors LP | 1.87M | 5.33% | +31.82% | Jun 2026 |
| Turtle Creek Asset Management Inc. | 1.69M | 4.81% | -1.51% | Sep 2026 |
| Vanguard Capital Management, LLC | 1.48M | 4.22% | +2.06% | Jun 2026 |
| Paradigm Capital Management, Inc. | 1.40M | 4.00% | -0.43% | Jun 2026 |
| FMR Inc | 1.18M | 3.37% | +7.21% | Jun 2026 |
| Arnhold & S. Bleichroeder Advisers, LLC | 1.14M | 3.25% | +164.73% | Jun 2026 |
| Seger Elvekrog Inc | 894K | 2.55% | -4.77% | Sep 2026 |
| The Goldman Sachs Group Inc | 891K | 2.54% | +41.18% | Jun 2026 |
| Geode Capital Management, LLC | 887K | 2.53% | +5.30% | Jun 2026 |
| Ameriprise Financial Inc | 875K | 2.49% | +0.29% | Jun 2026 |
| State Street Corp | 873K | 2.49% | +8.61% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 870K | 2.48% | +0.13% | Sep 2026 |
| Wellington Management Company LLP | 758K | 2.16% | -0.03% | Jun 2026 |
| Nuveen, LLC | 700K | 2.00% | +0.71% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 545K | 1.55% | +2.38% | Jun 2026 |
| BOONE CAPITAL MANAGEMENT LLC | 516K | 1.47% | 0.00% | Jun 2026 |
| Eversept Partners, LP | 460K | 1.31% | +47.44% | Jun 2026 |
| Victory Capital Management Inc. | 432K | 1.23% | -1.98% | Jun 2026 |
Pennant Group Inc company profile
- Company name
- Pennant Group Inc
- Ticker
- PNTG.US
- Exchange
- USA Stocks
- Listed since
- Oct 1, 2019
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 9,700
- Fiscal year end
- December
- Address
- 1675 East Riverside Drive, Eagle, ID, United States, 83616
- Phone
- 208 401 1400
- Website
- pennantgroup.com
About Pennant Group Inc
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities in Alabama, Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin, and Wyoming. The Company was incorporated in 2019 and is headquartered in Eagle, Idaho.
Pennant Group Inc management
6- Mr. Brent J. GuerisoliCEO & Chairman · born 1981
- Mr. John J. GochnourPresident & COO · born 1984
- Ms. Lynette B. Walbom CPAChief Financial Officer · born 1978
- Mr. Kirk S. Cheney J.D.Executive VP, General Counsel & Corporate Secretary · born 1982
- Mr. Jason P. SteikChief Clinical Officer · born 1984
- Andrew RiderPresident of Pinnacle Senior Living LLC